Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Ten-Year Statin Adherence in Survivors of ST-Segment Elevation Myocardial Infarction.

Huynh T, Lecca P, Montigny M, Gagnon R, Eisenberg MJ, Lauzon C, Mansour S, Rinfret S, Afilalo M, Nguyen M, Kouz S, Dery JP, Harvey R, Schampaert E, Tardif JC.

J Popul Ther Clin Pharmacol. 2018 Nov 6;25(2):e63-e77. doi: 10.22374/1710-6222.25.2.5.

PMID:
30725543
2.

Impact of an invasive strategy in the elderly hospitalized with acute coronary syndrome with emphasis on the nonagenarians.

Couture EL, Farand P, Nguyen M, Allard C, Wells GA, Mansour S, Rinfret S, Afilalo J, Eisenberg M, Montigny M, Kouz S, Afilalo M, Lauzon C, Dery JP, L'Allier P, Schampaert E, Tardif JC, Huynh T.

Catheter Cardiovasc Interv. 2018 Dec 1;92(7):E441-E448. doi: 10.1002/ccd.27877. Epub 2018 Sep 30.

PMID:
30269415
3.

Elevated level of lecithin:cholesterol acyltransferase (LCAT) is associated with reduced coronary atheroma burden.

Gebhard C, Rhainds D, He G, Rodés-Cabau J, Lavi S, Spence JD, Title L, Kouz S, L'Allier PL, Grégoire J, Ibrahim R, Cossette M, Guertin MC, Beanlands R, Rhéaume E, Tardif JC.

Atherosclerosis. 2018 Sep;276:131-139. doi: 10.1016/j.atherosclerosis.2018.07.025. Epub 2018 Jul 19.

PMID:
30059844
4.

Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study.

Perreault S, Shahabi P, Côté R, Dumas S, Rouleau-Mailloux É, Feroz Zada Y, Provost S, Mongrain I, Dorais M, Huynh T, Kouz S, Diaz A, Blostein M, de Denus S, Turgeon J, Ginsberg J, Lelorier J, Lalonde L, Busque L, Kassis J, Talajic M, Tardif JC, Dubé MP.

Clin Cardiol. 2018 May;41(5):576-585. doi: 10.1002/clc.22948. Epub 2018 May 15.

5.

Recurrent Cardiovascular Events in Survivors of Myocardial Infarction With ST-Segment Elevation (from the AMI-QUEBEC Study).

Huynh T, Montigny M, Iftikhar U, Gagnon R, Eisenberg M, Lauzon C, Mansour S, Rinfret S, Afilalo M, Nguyen M, Kouz S, Déry JP, Harvey R, De LaRocheliere R, Cantin B, Schampaert E, Tardif JC.

Am J Cardiol. 2018 Apr 15;121(8):897-902. doi: 10.1016/j.amjcard.2017.12.037. Epub 2018 Jan 31.

PMID:
29452691
6.

2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure.

Ezekowitz JA, O'Meara E, McDonald MA, Abrams H, Chan M, Ducharme A, Giannetti N, Grzeslo A, Hamilton PG, Heckman GA, Howlett JG, Koshman SL, Lepage S, McKelvie RS, Moe GW, Rajda M, Swiggum E, Virani SA, Zieroth S, Al-Hesayen A, Cohen-Solal A, D'Astous M, De S, Estrella-Holder E, Fremes S, Green L, Haddad H, Harkness K, Hernandez AF, Kouz S, LeBlanc MH, Masoudi FA, Ross HJ, Roussin A, Sussex B.

Can J Cardiol. 2017 Nov;33(11):1342-1433. doi: 10.1016/j.cjca.2017.08.022. Epub 2017 Sep 6.

PMID:
29111106
7.

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.

Lincoff AM, Nicholls SJ, Riesmeyer JS, Barter PJ, Brewer HB, Fox KAA, Gibson CM, Granger C, Menon V, Montalescot G, Rader D, Tall AR, McErlean E, Wolski K, Ruotolo G, Vangerow B, Weerakkody G, Goodman SG, Conde D, McGuire DK, Nicolau JC, Leiva-Pons JL, Pesant Y, Li W, Kandath D, Kouz S, Tahirkheli N, Mason D, Nissen SE; ACCELERATE Investigators.

N Engl J Med. 2017 May 18;376(20):1933-1942. doi: 10.1056/NEJMoa1609581.

8.

Outcomes of Patients With ST-Elevation Myocardial Infarction Receiving and Not Receiving Reperfusion Therapy: The Importance of Examining All Patients.

Lambert LJ, Brophy JM, Racine N, Rinfret S, L'Allier PL, Brown KA, Boothroyd LJ, Ross D, Segal E, Kouz S, Maire S, Harvey R, Kezouh A, Nasmith J, Bogaty P.

Can J Cardiol. 2016 Nov;32(11):1325.e11-1325.e18. doi: 10.1016/j.cjca.2016.02.073. Epub 2016 Mar 4.

PMID:
27265360
9.

Impact of revascularization in patients with sustained ventricular arrhythmias, prior myocardial infarction, and preserved left ventricular ejection fraction.

Mondésert B, Khairy P, Schram G, Shohoudi A, Talajic M, Andrade JG, Dubuc M, Guerra PG, Macle L, Roy D, Dyrda K, Thibault B, Barrero M, Diaz A, Kouz S, McNicoll S, Nowakowska D, Rivard L.

Heart Rhythm. 2016 Jun;13(6):1221-7. doi: 10.1016/j.hrthm.2016.01.019. Epub 2016 Jan 19.

PMID:
26806581
10.

Clinical Profiles Related to Timing of Death, Including In-Hospital Deaths Before Admission, in Patients With ST-Elevation Myocardial Infarction.

Bogaty P, L'Allier PL, Segal E, Rinfret S, Racine N, Harvey R, Ross D, Maire S, Kouz S, Carroll C, Boothroyd LJ, Kezouh A, Azzi L, Brown KA, Nasmith J, Lambert LJ.

Am J Cardiol. 2016 Feb 1;117(3):347-52. doi: 10.1016/j.amjcard.2015.10.053. Epub 2015 Nov 18.

PMID:
26721650
11.

The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice.

Howlett JG, Chan M, Ezekowitz JA, Harkness K, Heckman GA, Kouz S, Leblanc MH, Moe GW, O'Meara E, Abrams H, Ducharme A, Grzeslo A, Hamilton PG, Koshman SL, Lepage S, McDonald M, McKelvie R, Rajda M, Swiggum E, Virani S, Zieroth S; Canadian Cardiovascular Society Heart Failure Guidelines Panels.

Can J Cardiol. 2016 Mar;32(3):296-310. doi: 10.1016/j.cjca.2015.06.019. Epub 2015 Jun 25. Review.

PMID:
26391749
12.

The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implications.

Moe GW, Ezekowitz JA, O'Meara E, Lepage S, Howlett JG, Fremes S, Al-Hesayen A, Heckman GA, Abrams H, Ducharme A, Estrella-Holder E, Grzeslo A, Harkness K, Koshman SL, McDonald M, McKelvie R, Rajda M, Rao V, Swiggum E, Virani S, Zieroth S, Arnold JM, Ashton T, D'Astous M, Chan M, De S, Dorian P, Giannetti N, Haddad H, Isaac DL, Kouz S, Leblanc MH, Liu P, Ross HJ, Sussex B, White M; Canadian Cardiovascular Society.

Can J Cardiol. 2015 Jan;31(1):3-16. doi: 10.1016/j.cjca.2014.10.022. Epub 2014 Dec 19. Erratum in: Can J Cardiol. 2016 Mar;32(3):394.

PMID:
25532421
13.

CKM and LILRB5 are associated with serum levels of creatine kinase.

Dubé MP, Zetler R, Barhdadi A, Brown AM, Mongrain I, Normand V, Laplante N, Asselin G, Zada YF, Provost S, Bergeron J, Kouz S, Dufour R, Diaz A, de Denus S, Turgeon J, Rhéaume E, Phillips MS, Tardif JC.

Circ Cardiovasc Genet. 2014 Dec;7(6):880-6. doi: 10.1161/CIRCGENETICS.113.000395. Epub 2014 Sep 11.

PMID:
25214527
14.

Comparison of outcomes of ambulance users and nonusers in ST elevation myocardial infarction.

Boothroyd LJ, Lambert LJ, Segal E, Ross D, Kouz S, Maire S, Harvey R, Xiao Y, Brown KA, Nasmith J, Bogaty P.

Am J Cardiol. 2014 Nov 1;114(9):1289-94. doi: 10.1016/j.amjcard.2014.07.060. Epub 2014 Aug 12.

PMID:
25201215
15.

Impact of ECG findings and process-of-care characteristics on the likelihood of not receiving reperfusion therapy in patients with ST-elevation myocardial infarction: results of a field evaluation.

Brown KA, Lambert LJ, Brophy JM, Nasmith J, Rinfret S, Segal E, Kouz S, Ross D, Harvey R, Maire S, Boothroyd LJ, Bogaty P.

PLoS One. 2014 Aug 21;9(8):e104874. doi: 10.1371/journal.pone.0104874. eCollection 2014.

16.

Transfer of patients with ST-elevation myocardial infarction for primary percutaneous coronary intervention: a province-wide evaluation of "door-in to door-out" delays at the first hospital.

Lambert LJ, Brown KA, Boothroyd LJ, Segal E, Maire S, Kouz S, Ross D, Harvey R, Rinfret S, Xiao Y, Nasmith J, Bogaty P.

Circulation. 2014 Jun 24;129(25):2653-60. doi: 10.1161/CIRCULATIONAHA.113.007130. Epub 2014 Apr 17.

PMID:
24744277
17.

The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: focus on rehabilitation and exercise and surgical coronary revascularization.

Canadian Cardiovascular Society Heart Failure Management Primary Panel, Moe GW, Ezekowitz JA, O'Meara E, Howlett JG, Fremes SE, Al-Hesayen A, Heckman GA, Ducharme A, Estrella-Holder E, Grzeslo A, Harkness K, Lepage S, McDonald M, McKelvie RS, Nigam A, Rajda M, Rao V, Swiggum E, Virani S, Van Le V, Zieroth S; Canadian Cardiovascular Society Heart Failure Management Secondary Panel, Arnold JM, Ashton T, D'Astous M, Dorian P, Giannetti N, Haddad H, Isaac DL, Kouz S, Leblanc MH, Liu P, Ross HJ, Sussex B, White M.

Can J Cardiol. 2014 Mar;30(3):249-63. doi: 10.1016/j.cjca.2013.10.010. Epub 2013 Oct 19. Review.

PMID:
24480445
18.

Canada Acute Coronary Syndrome Risk Score: a new risk score for early prognostication in acute coronary syndromes.

Huynh T, Kouz S, Yan AT, Danchin N, O'Loughlin J, Schampaert E, Yan RT, Rinfret S, Tardif JC, Eisenberg MJ, Afilalo M, Chong A, Dery JP, Nguyen M, Lauzon C, Mansour S, Ko DT, Tu JV, Goodman S.

Am Heart J. 2013 Jul;166(1):58-63. doi: 10.1016/j.ahj.2013.03.023. Epub 2013 Apr 30. Erratum in: Am Heart J. 2013 Sep;166(3):604. Yan, Andrew [corrected to Yan, Andrew T]; Loughlin, Jennifer O [corrected to O'Loughlin, Jennifer]; Yan, Raymond [corrected to Yan, Raymond T].

PMID:
23816022
19.

The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure.

McKelvie RS, Moe GW, Ezekowitz JA, Heckman GA, Costigan J, Ducharme A, Estrella-Holder E, Giannetti N, Grzeslo A, Harkness K, Howlett JG, Kouz S, Leblanc K, Mann E, Nigam A, O'Meara E, Rajda M, Steinhart B, Swiggum E, Le VV, Zieroth S, Arnold JM, Ashton T, D'Astous M, Dorian P, Haddad H, Isaac DL, Leblanc MH, Liu P, Rao V, Ross HJ, Sussex B.

Can J Cardiol. 2013 Feb;29(2):168-81. doi: 10.1016/j.cjca.2012.10.007. Epub 2012 Nov 30. Review.

PMID:
23201056
20.

The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care.

McKelvie RS, Moe GW, Cheung A, Costigan J, Ducharme A, Estrella-Holder E, Ezekowitz JA, Floras J, Giannetti N, Grzeslo A, Harkness K, Heckman GA, Howlett JG, Kouz S, Leblanc K, Mann E, O'Meara E, Rajda M, Rao V, Simon J, Swiggum E, Zieroth S, Arnold JM, Ashton T, D'Astous M, Dorian P, Haddad H, Isaac DL, Leblanc MH, Liu P, Sussex B, Ross HJ.

Can J Cardiol. 2011 May-Jun;27(3):319-38. doi: 10.1016/j.cjca.2011.03.011. Review.

PMID:
21601772
21.

Effectiveness and safety of glycoprotein IIb/IIIa inhibitors in patients with myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of observational studies.

Kouz R, Kouz S, Schampaert E, Rinfret S, Tardif JC, Nguyen M, Eisenberg M, Harvey R, Afilalo M, Lauzon C, Dery JP, Mansour S, Huynh T.

Int J Cardiol. 2011 Dec 15;153(3):249-55. doi: 10.1016/j.ijcard.2010.08.019. Epub 2010 Oct 25.

PMID:
20971515
22.

Safety and effectiveness of enoxaparin following fibrinolytic therapy: Results of the Acute Myocardial Infarction (AMI)-QUEBEC registry.

El-Rayes M, Schampaert E, Tardif JC, Eisenberg MJ, Afilalo M, Kouz S, Lauzon C, Harvey R, Nguyen M, Kouz R, Dery JP, Mansour S, Van Kieu AM, Rinfret S, Huynh T.

Can J Cardiol. 2010 Oct;26(8):431-6.

23.

The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs.

Howlett JG, McKelvie RS, Costigan J, Ducharme A, Estrella-Holder E, Ezekowitz JA, Giannetti N, Haddad H, Heckman GA, Herd AM, Isaac D, Kouz S, Leblanc K, Liu P, Mann E, Moe GW, O'Meara E, Rajda M, Siu S, Stolee P, Swiggum E, Zeiroth S; Canadian Cardiovascular Society.

Can J Cardiol. 2010 Apr;26(4):185-202. Review.

24.

Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome.

Tardif JC, L'allier PL, Ibrahim R, Grégoire JC, Nozza A, Cossette M, Kouz S, Lavoie MA, Paquin J, Brotz TM, Taub R, Pressacco J.

Circ Cardiovasc Imaging. 2010 May;3(3):298-307. doi: 10.1161/CIRCIMAGING.110.937169. Epub 2010 Feb 27.

PMID:
20190281
25.

Successful thrombolysis of a stroke with a pulmonary embolism in a young woman.

Pelletier M, Bugeaud R, Ibrahim R, Morency G, Kouz S.

J Emerg Med. 2010 Oct;39(4):443-8. doi: 10.1016/j.jemermed.2009.02.033. Epub 2009 Apr 3.

PMID:
19345051
26.

Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials.

Howlett JG, McKelvie RS, Arnold JM, Costigan J, Dorian P, Ducharme A, Estrella-Holder E, Ezekowitz JA, Giannetti N, Haddad H, Heckman GA, Herd AM, Isaac D, Jong P, Kouz S, Liu P, Mann E, Moe GW, Tsuyuki RT, Ross HJ, White M; Canadian Cardiovascular Society.

Can J Cardiol. 2009 Feb;25(2):85-105.

27.

Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.

Tardif JC, Grégoire J, L'Allier PL, Ibrahim R, Lespérance J, Heinonen TM, Kouz S, Berry C, Basser R, Lavoie MA, Guertin MC, Rodés-Cabau J; Effect of rHDL on Atherosclerosis-Safety and Efficacy (ERASE) Investigators.

JAMA. 2007 Apr 18;297(15):1675-82. Epub 2007 Mar 26.

PMID:
17387133
28.

Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMI-QUEBEC Study.

Huynh T, O'Loughlin J, Joseph L, Schampaert E, Rinfret S, Afilalo M, Kouz S, Cantin B, Nguyen M, Eisenberg MJ; AMI-QUEBEC Study Investigators.

CMAJ. 2006 Dec 5;175(12):1527-32.

29.

Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study.

Dagenais GR, Yusuf S, Bourassa MG, Yi Q, Bosch J, Lonn EM, Kouz S, Grover J; HOPE Investigators.

Circulation. 2001 Jul 31;104(5):522-6.

PMID:
11479247
30.

Upstream use of tirofiban in patients admitted for an acute coronary syndrome in hospitals with or without facilities for invasive management. PRISM-PLUS Investigators.

Théroux P, Alexander J Jr, Dupuis J, Pesant Y, Gervais P, Grandmont D, Kouz S, Laramée P, Huynh T, Barr E, Sax FL; PRISM-PLUS Investigators.

Am J Cardiol. 2001 Feb 15;87(4):375-80.

PMID:
11179517
31.

Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina. The Canadian Lamifiban Study.

Théroux P, Kouz S, Roy L, Knudtson ML, Diodati JG, Marquis JF, Nasmith J, Fung AY, Boudreault JR, Delage F, Dupuis R, Kells C, Bokslag M, Steiner B, Rapold HJ.

Circulation. 1996 Sep 1;94(5):899-905.

PMID:
8790023
32.
33.

Atrial natriuretic factor: a possible link between left atrium, plasma volume, adrenergic control and renin-aldosterone in the mitral valve prolapse syndrome.

Pasternac A, Kouz S, Gutkowska J, Petitclerc R, Taillefer R, Cequier A, de Champlain J, Cantin M.

J Hypertens Suppl. 1986 Dec;4(5):S76-9.

PMID:
2952778
34.

[Experimental induction of sino-auricular blocks on isolated atria. Microelectrode study of the effects of bepridil].

Le Heuzey JY, Guize L, Valty J, Boutjdir M, Lavergne T, Kouz S, Peronneau P.

Arch Mal Coeur Vaiss. 1986 Apr;79(4):491-8. French.

PMID:
3090967
35.

Intracellular and extracellular recordings of sinus node activity: comparison with estimated sinoatrial conduction times during pacemaker shifts in rabbit heart.

Le Heuzey JY, Guize L, Valty J, Moutet JP, Kouz S, Lavergne T, Boutjdir M, Peronneau P.

Cardiovasc Res. 1986 Feb;20(2):81-8.

PMID:
3708650
36.

Risk of preangioplasty occlusion and myocardial infarction in one-vessel-disease patients scheduled for percutaneous transluminal coronary angioplasty.

Robert J, Bourassa MG, Moise A, Kouz S, Crepeau J, Bonan R, Chaitman BR, David PR, Salamon R.

Cathet Cardiovasc Diagn. 1986;12(5):292-7.

PMID:
2947689
37.

[Bifocal spastic angina. Choice of a calcium inhibitor].

Lardoux H, Bourdin T, Lairy G, Kouz S, Mermier P, Chouty F.

Presse Med. 1983 Jun 25;12(27):1727-8. French. No abstract available.

PMID:
6224171

Supplemental Content

Support Center